If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

Share Price is delayed by 15 minutes
Get Live Data
0.0825    0.0125 (17.86%)
Bid:
0.08
Ask:
0.085
Spread: 0.005 (6.25%)
Market Cap: £4.72m
EME Live PriceLast checked at - London Stock Exchange

Intraday Empyrean Share Chart

Form of Proxy

12 Sep 2014 07:40

RNS Number : 5062R
Empyrean Energy PLC
12 September 2014
 



Empyrean Energy Plc / Index: AIM / Epic: EME / Sector: Oil & Gas

 

12 September 2014

 

Empyrean Energy plc

 

Form of Proxy

Further to the announcement on 8 September 2014 regarding the Company's forthcoming Annual General Meeting (the "AGM"), the Company advises that, owing to a printing error in Resolution 2 as detailed in the Form of Proxy, revised Forms of Proxy have been posted to Shareholders.

Shareholders who have already submitted a Form of Proxy are advised to resubmit using the revised Form. The deadline for the receipt of the Form of Proxy for the AGM by the Company's registrars, Capita Asset Services, is 9.30am on 26 September 2014. Further details relating to the appointment of proxies are provided in the notes to the Form of Proxy.

**ENDS**

For further information please visit www.empyreanenergy.com or contact the following:

Tom Kelly

Empyrean Energy plc

Tel: +618 9481 0389

Neil McDonald

Cenkos Securities Plc

Tel: +44 (0) 131 220 9771 / +44 (0) 207 397 1953

Nick Tulloch

Cenkos Securities Plc

Tel: +44 (0) 131 220 9772 / +44 (0) 207 397 1950

Hugo De Salis

St Brides Media & Finance Ltd

Tel: +44 (0) 20 7236 1177

Elisabeth Cowell

St Brides Media & Finance Ltd

Tel: +44 (0) 20 7236 1177

Lottie Brocklehurst

St Brides Media & Finance Ltd

Tel: +44 (0) 20 7236 1177

 

Notes to Editors:

Empyrean Energy Plc is an AIM listed (Ticker: EME) profitable US on-shore oil and gas development and production company focussed primarily on the advancement of its assets in Texas and California. The Company's portfolio represents a mix of assets at various stages of development. Its flagship project is the Sugarloaf AMI in the prolific Eagle Ford Shale, Texas, where it has a 3% working interest in approximately 24,000 gross acres centrally positioned in the liquids rich sweet-spot within the field. Empyrean has an interest in 143 gross producing wells with full development expected to reach over 770. Further development of the Eagle Ford Shale anticipated to require in the order of a further 330 wells, with down spacing potential of approximately 200 further wells. Further development of the Austin Chalk anticipated to require in the order of a further 300 wells, with down spacing potential of approximately 235 further wells.

Other assets include a 57.2% interest in the Eagle Oil Pool Development Project located in the San Joaquin Basin, southern California, a proven oil and gas province. Empyrean's large working interest in this project provides the Company with flexibility and leverage with potential high impact from success. Additionally, Empyrean has a 7.5% interest in the Sugarloaf Block A operated by ConocoPhillips in the Eagle Ford Shale, and a 10% working interest in the Riverbend Project in Texas currently producing from the Wilcox formation.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQKBDNABKKPCD
Date   Source Headline
15th Jun 20127:00 amRNSFurther re: US$50m Debt Facility
31st May 20122:32 pmRNSResult of AGM
30th May 20124:15 pmRNSFurther re: US$50m Debt Facility
15th May 20128:15 amRNSAurora aquisition of 6% interest in Sugarloaf
8th May 20127:00 amRNSNotice of AGM and posting of results
3rd May 20127:47 amRNSOffer for Eureka Energy Limited by Aurora Oil&Gas
3rd May 20127:00 amRNSFinal Results
30th Apr 20129:14 amRNSOFFER FOR EUREKA ENERGY LIMITED BY AURORA OIL&GAS
18th Apr 20127:00 amRNSUS$50m Debt Facility
3rd Apr 20121:24 pmRNSConversion of Loan
27th Mar 201210:22 amRNSExercise of Options
23rd Mar 20127:00 amRNSEmpyeran mandates a US$50m Debt Facility
6th Mar 20122:30 pmRNSDirector/PDMR Shareholding
2nd Mar 201210:33 amRNSReplacement: US$1m sale of Hercules asset
2nd Mar 20128:27 amRNSUS$1m sale of Hercules asset and grant of options
1st Mar 20129:04 amRNSInstitutional Placing for £300,000
17th Feb 20121:29 pmRNSConversion of Loan
11th Jan 20127:24 amRNSSugarloaf Project Update
3rd Jan 20129:14 amRNSExtension of Convertible Loan Facility
22nd Dec 20117:26 amRNSTrading Statement
21st Dec 20117:06 amRNSSugarloaf Project Update
2nd Dec 20113:28 pmRNSReplacement: Half Yearly Report
2nd Dec 20117:00 amRNSHalf Yearly Report
1st Dec 20114:29 pmRNSConversion of Loan
1st Dec 20117:00 amRNSChange of Principal Office
28th Oct 201110:14 amRNSReplacement: Independent reserves report
28th Oct 20117:55 amRNSSugarloaf Project, Independent reserves report
27th Oct 20114:13 pmRNSConversion of Loan
25th Oct 20114:19 pmRNSConversion of Loan
24th Oct 20117:17 amRNSSugarloaf Project Update
19th Oct 20113:30 pmRNSConversion of Loan
15th Sep 20119:47 amRNSSugarloaf Project Update
31st Aug 201111:42 amRNSConversion of Loan - REPLACEMENT
24th Aug 20118:54 amRNSIssue of Equity
16th Aug 20119:43 amRNSDirector/PDMR Shareholding
15th Aug 20118:11 amRNSSugarloaf Update
19th Jul 20117:19 amRNSFurther re Sugarloaf Update
24th Jun 20111:30 pmRNSResult of AGM
14th Jun 20117:00 amRNSSugarloaf Project Update
3rd Jun 20117:59 amRNSTrading Statement
2nd Jun 20117:59 amRNSSugarloaf Project Update
31st May 201110:03 amRNSNotice of AGM
25th May 20117:00 amRNSFinal Results
13th May 20117:00 amRNSSugarloaf Project Update
29th Mar 201112:48 pmRNSGrant of options and Directorate change
22nd Mar 20118:22 amRNSInvestor Roadshow
10th Mar 20113:00 pmRNSDirector/PDMR Shareholding
9th Mar 20117:13 amRNSSugarloaf Project, Independent reserves report
28th Feb 20118:48 amRNSCORRECTION: Sugarloaf Update
28th Feb 20117:16 amRNSSugarloaf Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.